John E. Kao

Insider Reports History

Latest reporting-owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John E. Kao

Form 4 holding Chief Executive Officer, Director

Alignment Healthcare, Inc.

Security class: Common Stock
Shares / value: 1,386,766
Estimated value: $28,562,109
Report date: 10 Jun 2026
Price: $20.60
Ownership: Indirect

Form 4 holding Chief Executive Officer, Director

Alignment Healthcare, Inc.

Security class: Common Stock
Shares / value: 1,608,743
Estimated value: $28,346,051
Report date: 10 Jun 2026
Price: $17.62
Ownership: Direct

Insider Reports Filed by John E. Kao

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Jun 2026
Transactions: 2
Transaction value: -$6,066,621
Accepted by SEC: 12 Jun 2026, 16:03
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 May 2026
Transactions: 2
Transaction value: -$5,032,850
Accepted by SEC: 13 May 2026, 16:19
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Apr 2026
Transactions: 3
Transaction value: -$6,161,943
Accepted by SEC: 13 Apr 2026, 18:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 07 Apr 2026
Transactions: 2
Transaction value: -$5,252,911
Accepted by SEC: 08 Apr 2026, 17:48
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 23 Mar 2026
Transactions: 1
Transaction value: -$2,062,439
Accepted by SEC: 23 Mar 2026, 17:36
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 18 Mar 2026
Transactions: 1
Transaction value: -$1,303,141
Accepted by SEC: 19 Mar 2026, 18:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Mar 2026, 17:13
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 12 Mar 2026
Transactions: 2
Transaction value: -$853,126
Accepted by SEC: 13 Mar 2026, 18:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Mar 2026
Transactions: 1
Transaction value: -$3,273,552
Accepted by SEC: 10 Mar 2026, 19:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Feb 2026
Transactions: 1
Transaction value: -$3,687,354
Accepted by SEC: 10 Feb 2026, 21:50
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 12 Jan 2026
Transactions: 2
Transaction value: -$3,799,219
Accepted by SEC: 14 Jan 2026, 16:28
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 29 Dec 2025
Transactions: 2
Transaction value: -$11,351,467
Accepted by SEC: 30 Dec 2025, 16:53
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Dec 2025
Transactions: 1
Transaction value: -$3,423,222
Accepted by SEC: 12 Dec 2025, 16:32
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Nov 2025
Transactions: 1
Transaction value: -$2,936,772
Accepted by SEC: 12 Nov 2025, 18:28
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Oct 2025
Transactions: 1
Transaction value: -$3,111,480
Accepted by SEC: 14 Oct 2025, 16:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 10 Sep 2025
Transactions: 3
Transaction value: -$8,779,961
Accepted by SEC: 10 Sep 2025, 20:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Aug 2025
Transactions: 1
Transaction value: -$2,627,838
Accepted by SEC: 13 Aug 2025, 16:22
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 16 Jun 2025
Transactions: 1
Transaction value: -$1,302,849
Accepted by SEC: 17 Jun 2025, 19:42
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Jun 2025
Transactions: 1
Transaction value: -$1,374,201
Accepted by SEC: 12 Jun 2025, 17:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 12 May 2025
Transactions: 1
Transaction value: -$1,335,429
Accepted by SEC: 14 May 2025, 17:01
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 14 Apr 2025
Transactions: 1
Transaction value: -$1,718,721
Accepted by SEC: 16 Apr 2025, 17:02
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 27 Mar 2025
Transactions: 1
Transaction value: -$615,953
Accepted by SEC: 28 Mar 2025, 20:27
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 18 Mar 2025
Transactions: 3
Transaction value: -$1,024,371
Accepted by SEC: 19 Mar 2025, 21:48
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Mar 2025, 17:59
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Mar 2025
Transactions: 4
Transaction value: -$2,201,771
Accepted by SEC: 13 Mar 2025, 17:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 04 Mar 2025
Transactions: 2
Transaction value: -$8,614,693
Accepted by SEC: 06 Mar 2025, 19:27
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Feb 2025
Transactions: 1
Transaction value: -$1,280,304
Accepted by SEC: 12 Feb 2025, 18:58
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Jan 2025
Transactions: 2
Transaction value: -$1,175,494
Accepted by SEC: 13 Jan 2025, 18:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Dec 2024
Transactions: 1
Transaction value: -$1,048,689
Accepted by SEC: 13 Dec 2024, 17:40
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Nov 2024
Transactions: 1
Transaction value: -$1,207,944
Accepted by SEC: 13 Nov 2024, 17:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 09 Oct 2024
Transactions: 1
Transaction value: -$1,019,538
Accepted by SEC: 10 Oct 2024, 18:57
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 16 Sep 2024
Transactions: 1
Transaction value: -$1,052,874
Accepted by SEC: 18 Sep 2024, 16:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 25 Mar 2024
Transactions: 2
Transaction value: -$2,568,067
Accepted by SEC: 11 Jul 2025, 17:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 14 Mar 2024
Transactions: 1
Transaction value: +$496,779
Accepted by SEC: 18 Mar 2024, 17:27
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Mar 2024, 20:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4/A ALHC

Alignment Healthcare, Inc.

Report period: 08 Mar 2024
Transactions: 1
Transaction value: -$192,967
Accepted by SEC: 11 Jul 2025, 17:07
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 29 Mar 2023
Transactions: 1
Transaction value: -$210,946
Accepted by SEC: 31 Mar 2023, 17:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 14 Mar 2023
Transactions: 1
Transaction value: -$247,392
Accepted by SEC: 15 Mar 2023, 18:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 18 Jan 2023
Transactions: 1
Transaction value: -$14,310
Accepted by SEC: 20 Jan 2023, 17:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 01 Dec 2022
Transactions: 1
Transaction value: -$327,778
Accepted by SEC: 02 Dec 2022, 18:21
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 01 Nov 2022
Transactions: 1
Transaction value: -$330,830
Accepted by SEC: 02 Nov 2022, 16:25
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 26 Oct 2022
Transactions: 1
Transaction value: -$326,855
Accepted by SEC: 28 Oct 2022, 16:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 12 Sep 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Sep 2022, 18:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 01 Sep 2022
Transactions: 1
Transaction value: -$727,935
Accepted by SEC: 02 Sep 2022, 16:13
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Aug 2022
Transactions: 1
Transaction value: -$7,976,450
Accepted by SEC: 12 Aug 2022, 16:32
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 05 Aug 2022
Transactions: 2
Transaction value: -$1,228,889
Accepted by SEC: 09 Aug 2022, 16:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 01 Aug 2022
Transactions: 2
Transaction value: -$730,094
Accepted by SEC: 02 Aug 2022, 21:18
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 11 Jul 2022
Transactions: 1
Transaction value: -$57,808
Accepted by SEC: 11 Jul 2022, 17:55
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 06 Jul 2022
Transactions: 4
Transaction value: -$1,321,662
Accepted by SEC: 08 Jul 2022, 18:41
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 31 Mar 2022
Transactions: 1
Transaction value: -$294,656
Accepted by SEC: 01 Apr 2022, 18:49
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 08 Mar 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 10 Mar 2022, 16:21
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 23 Nov 2021
Transactions: 1
Transaction value: -$8,438,032
Accepted by SEC: 24 Nov 2021, 17:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 01 Nov 2021
Transactions: 2
Transaction value: -$1,991,617
Accepted by SEC: 03 Nov 2021, 16:56
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Oct 2021
Transactions: 3
Transaction value: -$3,706,010
Accepted by SEC: 15 Oct 2021, 19:39
Role: Chief Executive Officer, Director
Next action: Open filing details

3/A ALHC

Alignment Healthcare, Inc.

Report period: 26 Mar 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 13 May 2021, 17:22
Role: Chief Executive Officer, Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for John E. Kao

Insider Reports Filed by John E. Kao